Tag: Finch Therapeutics

BTD for FInch’s C. Difficile Drug

Finch Therapeutics Group has secured breakthrough therapy designation from the US Food and Drug Administration (FDA) for its investigational drug CP101 to treat patients with recurrent Clostridium dif...